These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 28235628

  • 1. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
    Roitman PD, Jauk F, Farfalli GL, Albergo JI, Aponte-Tinao LA.
    Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
    [Abstract] [Full Text] [Related]

  • 2. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 3. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
    Kumar R, Mallya V, Mandal S, Tomar R, Khurana N, Maini L.
    J Cancer Res Ther; 2023 Jan; 19(3):768-772. PubMed ID: 37470608
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 5. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH, Liu WF, Ding Y, Zhang W, Yang YK, Yu F, Wong GQ, Huang XY, Niu XH.
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun 08; 47(6):449-454. PubMed ID: 29886590
    [Abstract] [Full Text] [Related]

  • 6. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
    Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, Rivera MN, Ting DT, Resnick CM, Peacock ZS, Kaban LB, Deshpande V.
    Am J Surg Pathol; 2019 Jun 08; 43(6):819-826. PubMed ID: 30998511
    [Abstract] [Full Text] [Related]

  • 7. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 15; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 9. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme.
    Erdogan KE, DevecI MA, Paydas S, Gonlusen G.
    Pol J Pathol; 2016 May 15; 67(4):392-397. PubMed ID: 28547968
    [Abstract] [Full Text] [Related]

  • 10. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A.
    J Clin Pathol; 2016 Mar 15; 69(3):240-7. PubMed ID: 26338802
    [Abstract] [Full Text] [Related]

  • 11. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
    Chow LT.
    Virchows Arch; 2016 Jun 15; 468(6):741-55. PubMed ID: 27003154
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
    Pathol Oncol Res; 2017 Jan 15; 23(1):157-164. PubMed ID: 27722984
    [Abstract] [Full Text] [Related]

  • 13. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T, Kawashima H, Ogose A, Ariizumi T, Sasaki T, Hatano H, Hotta T, Endo N.
    PLoS One; 2016 Jan 15; 11(5):e0154680. PubMed ID: 27163152
    [Abstract] [Full Text] [Related]

  • 14. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology.
    Treffel M, Lardenois E, Larousserie F, Karanian M, Gomez-Brouchet A, Bouvier C, Le Loarer F, Aubert S, de Pinieux G, Audard V, Rios M, Sirveaux F, Vignaud JM, Gauchotte G, Marie B.
    Am J Surg Pathol; 2020 Jan 15; 44(1):1-10. PubMed ID: 31651524
    [Abstract] [Full Text] [Related]

  • 15. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
    Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S.
    Lancet Oncol; 2010 Mar 15; 11(3):275-80. PubMed ID: 20149736
    [Abstract] [Full Text] [Related]

  • 16. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA, Paydaş S, Gönlüşen G, Özkan C, Biçer ÖS, Tekin M.
    Acta Orthop Traumatol Turc; 2017 Jan 15; 51(1):1-6. PubMed ID: 27784623
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
    Rosario M, Takeuchi A, Yamamoto N, Hayashi K, Miwa S, Higuchi T, Abe K, Taniguchi Y, Aiba H, Tanzawa Y, Murakami H, Tsuchiya H.
    Anticancer Res; 2017 Feb 15; 37(2):749-754. PubMed ID: 28179326
    [Abstract] [Full Text] [Related]

  • 18. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G.
    Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.